Nonparoxysmal atrial fibrillation continues to challenge electrophysiologist and surgeons alike. Stand-alone endocardial catheter ablation has resulted in less than satisfying results, and while the on-pump Cox-Maze surgery has excellent results, the invasiveness has limited its adoption amongst both referring providers and surgeons. The CONVERGE IDE trial has shed new light on this once dim problem. EPs and Surgeons are now working together in a Hybrid Team Ablation Approach to provide a combined ablation strategy that has improved patient outcomes and rekindled the collaboration necessary to better patient outcomes. We herein summarize the current Hybrid Team Ablation Approaches (CONVERGE and Totally Thoracoscopic) with nonparoxysmal atrial fibrillation.